Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Schmidt

Showing results (11-20 of 343) with videos related to

Pageof 35
Sort By:
Breast Care (Basel, Switzerland)|December 21, 2023
Breast Cancer Outcome: What Have We AchievedVolker Möbus, Marcus Schmidt
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Palbociclib-The First of a New Class of Cell Cycle InhibitorsMarcus Schmidt, Martin Sebastian
Breast (Edinburgh, Scotland)|October 15, 2024
Chemotherapy in older patients with early breast cancerMarcus Schmidt, Sibylle Loibl
Sports Medicine - Open|December 11, 2021
The ANHEQ Evaluation Criteria: Introducing Reliable Rating Scales for Assessing Nordic Hamstring Exercise QualityTobias Alt, Marcus Schmidt
Critical Reviews in Food Science and Nutrition|March 31, 2023
FODMAP reduction strategies for nutritionally valuable baking products: current state and future challengesMarcus Schmidt, Marianna Raczyk
Breast Care (Basel, Switzerland)|November 12, 2015
Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast CancerKatrin Almstedt, Marcus Schmidt
Oncology Research and Treatment|December 16, 2021
New Opportunities in Advanced Breast CancerThomas Decker, Marcus Schmidt
Therapeutic Advances in Medical Oncology|September 12, 2018
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancerMarc Thill, Marcus Schmidt
Cancers|October 13, 2021
Immunomodulating Therapies in Breast Cancer-From Prognosis to Clinical PracticeMarcus Schmidt, Anne-Sophie Heimes
Expert Opinion on Investigational Drugs|November 27, 2018
Atezolizumab for the treatment of triple-negative breast cancerAnne-Sophie Heimes, Marcus Schmidt
Pageof 35

Showing results (11-20 of 343) with videos related to

Sort By:
Pageof 35
Breast Care (Basel, Switzerland)|December 21, 2023
Breast Cancer Outcome: What Have We AchievedVolker Möbus, Marcus Schmidt
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Palbociclib-The First of a New Class of Cell Cycle InhibitorsMarcus Schmidt, Martin Sebastian
Breast (Edinburgh, Scotland)|October 15, 2024
Chemotherapy in older patients with early breast cancerMarcus Schmidt, Sibylle Loibl
Sports Medicine - Open|December 11, 2021
The ANHEQ Evaluation Criteria: Introducing Reliable Rating Scales for Assessing Nordic Hamstring Exercise QualityTobias Alt, Marcus Schmidt
Critical Reviews in Food Science and Nutrition|March 31, 2023
FODMAP reduction strategies for nutritionally valuable baking products: current state and future challengesMarcus Schmidt, Marianna Raczyk
Breast Care (Basel, Switzerland)|November 12, 2015
Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast CancerKatrin Almstedt, Marcus Schmidt
Oncology Research and Treatment|December 16, 2021
New Opportunities in Advanced Breast CancerThomas Decker, Marcus Schmidt
Therapeutic Advances in Medical Oncology|September 12, 2018
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancerMarc Thill, Marcus Schmidt
Cancers|October 13, 2021
Immunomodulating Therapies in Breast Cancer-From Prognosis to Clinical PracticeMarcus Schmidt, Anne-Sophie Heimes
Expert Opinion on Investigational Drugs|November 27, 2018
Atezolizumab for the treatment of triple-negative breast cancerAnne-Sophie Heimes, Marcus Schmidt
Pageof 35